Psy82 - Annual Cost of Clotting Factors in Patients With Severe (Sev) Hemophilia a (Ha) in France

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2657
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Diagnostic Values of Inflammatory and Angiogenic Factors for Acute Joint Bleeding in Patients With Severe Hemophilia A

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2020English

44 Aspects of Prenatal Diagnosis in Hemophilia a (Ha) and B (Hb)

Pediatric Research
Child HealthPediatricsPerinatology
1994English

Activation State of Platelets in Experimental Severe Hemophilia A

Haematologica
Hematology
2012English

The Effects of Postponing Prophylactic Treatment on Long-Term Outcome in Patients With Severe Hemophilia

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

Cancers in Patients With Hemophilia: A Retrospective Study From the Italian Association of Hemophilia Centers

Journal of Thrombosis and Haemostasis
MedicineHematology
2012English

Severe Hemophilia B

2020English

Cost-Effectiveness of Roflumilast in Combination With Bronchodilator Therapies in Patients With Severe and Very Severe COPD in Switzerland

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2013English

Obesity and Overweight in Patients With Hemophilia

Journal of the Chinese Medical Association
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy